
|Videos|October 21, 2022
Dr. Chughtai explains how "less is more" approach has implications for BPH
Author(s)Urology Times staff
“For practicing urologists, I think it's important for us to recognize that when it comes to these techniques, even with Rezum, there's a variety of ways of doing them," says Bilal Chughtai, MD.
Advertisement
In this interview, Bilal Chughtai, MD, discusses the implications of his recent publication “Pilot study of ‘less is more’ Rezum for treatment of BPH.” Dr. Chugtai is a urologist at Weill Cornell Medical College in New York, NY.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves first-line Zenflow system for the treatment of BPH
2
Mohit Khera, MD, recaps key takeaways from FDA panel on TRT for men
3
FDA approves niraparib plus abiraterone acetate with prednisone for BRCA2+ mCSPC
4
EMA recommends conditional approval of Anktiva in BCG-unresponsive NMIBC
5

















